Zobrazeno 1 - 10
of 573
pro vyhledávání: '"Boireau S"'
Autor:
Gonzalez-Menendez P; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France., Phadke I; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France.; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD., Olive ME; Proteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA., Joly A; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France., Papoin J; Feinstein Institute for Medical Research, Manhasset, NY.; EA4666 HEMATIM, Université Picardie Jules Verne, Amiens, France., Yan H; New York Blood Center, New York, NY., Galtier J; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France., Platon J; EA4666 HEMATIM, Université Picardie Jules Verne, Amiens, France., Kang SWS; Thoracic and GI Malignancies Branch, NCI, CCR, NIH, Bethesda, MD., McGraw KL; Laboratory of Receptor Biology and Gene Expression, NCI, CCR, NIH, Bethesda, MD., Daumur M; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France., Pouzolles M; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD., Kondo T; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD., Boireau S; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Montpellier Ressources Imagerie, BioCampus, University of Montpellier, CNRS, INSERM, Montpellier, France., Paul F; Department of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Young DJ; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD., Lamure S; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Department of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Mirmira RG; Department of Medicine, The University of Chicago, Chicago, IL., Narla A; Division of Pediatric Hematology/Oncology, Stanford University, Stanford, CA., Cartron G; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Department of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Dunbar CE; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD., Boyer-Clavel M; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France., Porat-Shliom N; Thoracic and GI Malignancies Branch, NCI, CCR, NIH, Bethesda, MD., Dardalhon V; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France., Zimmermann VS; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France., Sitbon M; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France., Dever TE; Section on Protein Biosynthesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD., Mohandas N; New York Blood Center, New York, NY., Da Costa L; Laboratory of Excellence GR-Ex, Paris, France.; EA4666 HEMATIM, Université Picardie Jules Verne, Amiens, France.; Service d'Hématologie Biologique (Hematology Diagnostic Laboratory), Assistance Publique-Hôpitaux de Paris, Robert Debr Hôpital, Paris, France.; Paris Cité University, Paris, France., Udeshi ND; Proteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA., Blanc L; Feinstein Institute for Medical Research, Manhasset, NY., Kinet S; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France., Taylor N; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.; Laboratory of Excellence GR-Ex, Paris, France.; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD.
Publikováno v:
Blood [Blood] 2023 May 18; Vol. 141 (20), pp. 2520-2536.
Autor:
Boulay A; Viral Trafficking, Restriction and Innate Signaling, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, Montpellier, France., Trabanelli S; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland., Boireau S; Montpellier Ressources Imagerie, Biocampus, Université de Montpellier, CNRS, Montpellier, France., Boyer-Clavel M; Montpellier Ressources Imagerie, Biocampus, Université de Montpellier, CNRS, Montpellier, France., Nisole S; Viral Trafficking, Restriction and Innate Signaling, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, Montpellier, France., Romero P; Department of Oncology, University of Lausanne, Épalinges, Switzerland., Jandus C; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland., Beignon AS; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Arhel NJ; Viral Trafficking, Restriction and Innate Signaling, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, Montpellier, France.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2023 Mar 01; Vol. 7 (3), pp. 243-255.
Autor:
Begon-Pescia C; CNRS, LPHI, Universite Montpellier, Montpellier, France., Boireau S; Montpellier Ressources Imagerie, Biocampus, CNRS, INSERM, Universite Montpellier, Montpellier, France., Boyer-Clavel M; Montpellier Ressources Imagerie, Biocampus, CNRS, INSERM, Universite Montpellier, Montpellier, France., Lutfalla G; CNRS, LPHI, Universite Montpellier, Montpellier, France., Nguyen-Chi M; CNRS, LPHI, Universite Montpellier, Montpellier, France.
Publikováno v:
MethodsX [MethodsX] 2022 Mar 09; Vol. 9, pp. 101651. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).
Autor:
Alaterre E; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Ovejero S; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Herviou L; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., de Boussac H; Diag2Tec, Montpellier, France., Papadopoulos G; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Kulis M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Boireau S; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Robert N; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Requirand G; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Bruyer A; Diag2Tec, Montpellier, France., Cartron G; Clinical Hematology. CHU Montpellier, Montpellier, France.; University of Montpellier, UFR Medicine, Montpellier, France.; UMR-CNRS 5535, Institut de Génétique Moléculaire de Montpellier, 34090 Montpellier, France., Vincent L; Clinical Hematology. CHU Montpellier, Montpellier, France., Martinez AM; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Martin-Subero JI; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain.; Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Cavalli G; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Moreaux J; Department of Biological Hematology, CHU Montpellier, Montpellier, France.; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.; University of Montpellier, UFR Medicine, Montpellier, France.; Institut Universitaire de France (IUF).
Publikováno v:
Theranostics [Theranostics] 2022 Jan 16; Vol. 12 (4), pp. 1715-1729. Date of Electronic Publication: 2022 Jan 16 (Print Publication: 2022).
Dosage suppressors of gpn2ts mutants and functional insights into the role of Gpn2 in budding yeast.
Autor:
Wang, Le1 (AUTHOR), Li, Pan2 (AUTHOR), Zeng, Pei1 (AUTHOR), Xie, Debao1 (AUTHOR), Gao, Mengdi1 (AUTHOR), Ma, Lujie1 (AUTHOR), Sohail, Aamir1 (AUTHOR), Zeng, Fanli1 (AUTHOR) fanli.zeng@pku.edu.cn
Publikováno v:
PLoS ONE. 12/6/2024, Vol. 19 Issue 12, p1-17. 17p.
Autor:
Zhang, Yun1 (AUTHOR), Simko, Alexandria Carrasquillo2 (AUTHOR), Okoro, Uzondu1 (AUTHOR), Sibert, Deja Jamese2 (AUTHOR), Moon, Jin Hyung2 (AUTHOR), Liu, Bin3 (AUTHOR), Matin, Angabin2 (AUTHOR) matin_a@mercer.edu
Publikováno v:
Bioinformatics & Biology Insights. 10/15/2024, p1-15. 15p.
Publikováno v:
Greffage électrochimique de nanoparticules d'or Nanohybrides
Greffage électrochimique de nanoparticules d'or Nanohybrides, May 2013, Porquerolles, France
Greffage électrochimique de nanoparticules d'or Nanohybrides, May 2013, Porquerolles, France
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5b1e45c05558b1b964f5aee532d00fdd
https://hal.archives-ouvertes.fr/hal-00846642
https://hal.archives-ouvertes.fr/hal-00846642
Autor:
Cisneros, William J.1,2 (AUTHOR), Soliman, Shimaa H. A.3 (AUTHOR), Walter, Miriam1 (AUTHOR), Simons, Lacy M.1,2 (AUTHOR), Cornish, Daphne1,2 (AUTHOR), De Fabritiis, Simone3 (AUTHOR), Halle, Ariel W.1,2 (AUTHOR), Kim, Eun-Young1 (AUTHOR), Wolinsky, Steven M.1 (AUTHOR), Lorenzo-Redondo, Ramon1,2 (AUTHOR), Shilatifard, Ali3 (AUTHOR), Hultquist, Judd F.1,2 (AUTHOR) judd.hultquist@northwestern.edu
Publikováno v:
PLoS Pathogens. 9/11/2024, Vol. 20 Issue 9, p1-32. 32p.
Autor:
Pessoa, João1,2 (AUTHOR) celiacarv@edu.ulisboa.pt, Carvalho, Célia1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8411. 31p.
Autor:
Requirand G; CHU Montpellier, Department of Biological Hematology, Montpellier, France.; IGH, CNRS, University of Montpellier, Montpellier, France., Robert N; CHU Montpellier, Department of Biological Hematology, Montpellier, France.; IGH, CNRS, University of Montpellier, Montpellier, France., Boireau S; CHU Montpellier, Department of Biological Hematology, Montpellier, France.; IGH, CNRS, University of Montpellier, Montpellier, France., Vincent L; CHU Montpellier, Department of Clinical Hematology, Montpellier, France., Seckinger A; Medizinische Klinik und Poliklinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Bouhya S; CHU Montpellier, Department of Clinical Hematology, Montpellier, France., Ceballos P; CHU Montpellier, Department of Clinical Hematology, Montpellier, France., Cartron G; CHU Montpellier, Department of Clinical Hematology, Montpellier, France.; University of Montpellier, UFR de Médecine, Montpellier, France., Hose D; Medizinische Klinik und Poliklinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Klein B; CHU Montpellier, Department of Biological Hematology, Montpellier, France.; IGH, CNRS, University of Montpellier, Montpellier, France.; University of Montpellier, UFR de Médecine, Montpellier, France., Moreaux J; CHU Montpellier, Department of Biological Hematology, Montpellier, France.; IGH, CNRS, University of Montpellier, Montpellier, France.; University of Montpellier, UFR de Médecine, Montpellier, France.; UMR CNRS 5235, University of Montpellier, Montpellier, France.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2019 May; Vol. 96 (3), pp. 209-214. Date of Electronic Publication: 2018 Nov 12.